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ABSTRACT
Many diseases commonly associated with aging are now thought to have social and
physiologic antecedents in early life. Understanding how the timing of exposure to
early life risk factors influences later-life health may illuminate mechanisms driving
adult health inequalities and identify possible points for effective interventions.
Recognizing chronic diseases as developing across the lifecourse also has implications
for the conduct of research on adult risk factors for disease. We review alternative
conceptual models that describe how the timing of risk factor exposure relates to the
development of disease. We propose some expansions of lifecourse models to
improve their relevance for research on adult chronic disease, using the relationship
between education and adult cognitive decline and dementia as an example.
We discuss the important implications each of the lifecourse conceptual models has
on study design, analysis, and interpretation of research on aging and chronic
diseases. We summarize several research considerations implied by the lifecourse
framework, including: advantages of analyzing change in function rather than onset
of impairment; the pervasive challenge of survivor bias; the importance of
controlling for possible confounding by early life conditions; and the likely
heterogeneity in responses of adults to treatment.
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INTRODUCTION
Accumulating evidence from lifecourse epidemiology indicates that many
diseases typically diagnosed in adulthood have social and physiologic
antecedents much earlier in life.1-3 Although the research faces many analytic
challenges, the fundamental premise – illnesses of middle and late life are
often shaped by developmental processes experienced in utero, in childhood,
in adolescence or early adulthood – has strong empirical support.4-6 This
result has several important implications for appropriate design, analysis,
and interpretation of research on aging and chronic diseases. In many cases,
an understanding of the role of early life conditions is relevant even for
substantive research questions relating to exposures or outcomes exclusively
encountered in adults. Research on adult chronic diseases focuses on
identifying opportunities to intervene to improve population health, whether
via clinical treatments, behavioral interventions, or policy changes.
Understanding the lifecourse antecedents of diseases associated with aging
can provide essential insight into selecting the timing and structure of
interventions in order to successfully improve population health.7 Lifecourse
epidemiology can both highlight new or unrecognized opportunities for
improving population health and inform methods to test long-standing
hypotheses about the determinants of adult disease. These models are also
valuable for understanding the likely population health trends in a world
undergoing a rapid demographic transformation. In some cases, lifecourse
epidemiology suggests the stage was set for major population health changes
decades ago, during the early lives of current cohorts of adults.
In this paper, we summarize the alternative etiologic models in lifecourse
epidemiology, discuss limitations in the current literature, and propose
some expansions of lifecourse models to improve their relevance for
research on adult chronic disease. These models are important because
paradigms for the development of adult disease shape the research questions
we ask and the methods used to address such questions. Applying a life
course perspective challenges researchers to consider the dynamic process
and multidimensional nature of health and well-being in adulthood. After
reviewing examples of such conceptual representations, we discuss several
implications of these models for research on determinants of adult disease:
the value of analyzing change in function rather than onset of impairment
whenever possible; the pervasive challenge of survivor bias; the importance
of controlling for possible confounding by early life conditions; and the
likely heterogeneity in responses of adults to treatment.
For clarity, we illustrate our discussion with the example of the effects of
education and cognitive stimulation on adult cognitive decline and dementia.
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We consider possible benefits of education to be mediated by immersion in a
cognitively stimulating environment, characterized by novelty and intellectual
challenges, and assume that an individual may have such experiences at any
time in life, via work or leisure activities, even if not participating in formal
education. The possible effects of both educational attainment and adult
cognitive engagement on dementia and cognitive decline are active research
areas.8-11 The importance of lifecourse models for understanding cognitive
aging and dementia has recently received increased attention.12-15 However,
many of the ideas are immediately relevant to other outcomes, such as disability.
LIFECOURSE EPIDEMIOLOGY FRAMEWORKS

Fig. 1. Alternative lifecourse models linking the timing of exposure to stimulating
cognitive environment and dementia risk. (a) Immediate risk; (b) Social trajectory;
(c) Cumulative risk; (d) Early life latency; (e) Social mobility effects.
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Lifecourse epidemiology takes as a principle that, although many diseases
are primarily diagnosed in old age, such conditions may nonetheless reflect
damage (or benefits) incurred from exposures much earlier in life. Although
the exact characterizations of alternative lifecourse models differ slightly
across the published literature, researchers distinguish among competing
models linking the timing of exposure to a potential risk factor to the
manifestation of disease (Figure 1a-e).3,16 We use “risk factor” here to
indicate an exposure or treatment that affects health, not merely a marker
for such an exposure. For example we focus on exposures that would
increase risk of disease for an individual who was exposed to the risk factor
compared to the risk the individual would have had if he or she had not been
exposed.17 The distinction between such a causal risk factor and proxies or
markers for causal risk factors is that causal risk factors suggest opportunities
for interventions to improve health, whereas changing markers or proxies
for causal agents is not anticipated to provide health benefits.
Immediate effects models posit brief etiologic periods so that exposure
to a causal risk factor increases risk of disease quite promptly.18 In other
words, it assumes individuals experience a decrease in disease risk
concurrently or shortly after the risk factor is removed. For example, Figure
1a represents the assumption that low levels of cognitive stimulation in
midlife immediately affect dementia risk, and educational or cognitive
experiences in childhood or early adulthood are irrelevant. In this model,
childhood education has no effect on dementia, either directly or mediated
through adult cognitive experiences. Interventions to enrich the cognitive
environments of children would not be expected to have any effect in this
model, but late life interventions would be expected to be beneficial.
Many exposures, particularly those related to social position follow a
“sticky” trajectory, where childhood conditions shape adult exposures. For
these exposures, social trajectory models (Figure 1b) are more appropriate
than immediate risk models. For example, high-quality childhood education
may enable someone to obtain a challenging and engaging job, whereas
poor childhood education may lead to monotonous work. In this case, if
adult cognitive engagement affects dementia risk (as in the immediate risk
model) then childhood education will also affect dementia risk via its
influence on adult cognitive engagement. In Figure 1b, there is no direct
effect of childhood exposure on adult outcomes, it is only the adult exposure
that directly harms (or in this case, benefits) adult health. These cascading
models are sometimes called “chain of risk” or “risk of risk” models. This
model suggests there may be several options for designing effective
interventions, because intervention in either childhood or adulthood could
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be beneficial. To identify the most promising opportunities it is helpful to
consider possible “elbow” or “lever” periods, when the intervention would
have the largest effects on the exposure. Such “elbows” occur when the
direction of future exposure trajectory is most malleable; possible turning
points might occur during the first encounter with formal schooling, at the
moment of transition from school to work, or at retirement.
In contrast to social trajectory models, which assume that early life
social factors do not “get under the skin” but only increase risk of future
damage, cumulative biological models posit that each period of risk factor
exposure induces permanent physiologic harm (Figure 1c). This damage
accumulates over the lifecourse, increasing risk of later illness with each
additional exposure period. Even if the risk is removed in adulthood, the
individual will still experience the physiologic damage accumulated prior
to removal. Cumulative biological models often seem the most plausible
description of risk-factor-health associations. Allostatic load models are
premised on the accumulation of physical damage over the lifecourse.19,20
Cumulative models may be especially apt for social risk factors. There are
often many possible pathways via which social risk factors affect health,
and different mechanisms may be relevant at different points in the
pathway.21 However, physical toxins such as lead may also have cumulative
biological effects on adult cognitive outcomes. For some diseases, including
dementia, the diagnosis of the disease typically occurs long after the initial
physiologic damage begins. The diagnosis is the tail end of a long,
accumulating pathologic process. The cumulative biological model can
also incorporate the concept of historically linked lives and intergenerational
transfer of risk. Previous studies have suggested parental health and health
behaviors have direct and early effects on their children, placing them at
greater risk for subsequent detrimental health outcomes.22,23
For some exposures, there may be an especially sensitive window of
time during which the exposure is extremely influential, and after the
temporal window closes, the exposure is no longer relevant. Such sensitive
period or latency models typically invoke a key developmental period.
For example, periods of rapid tissue growth, development of aspects of
neurologic “architectural” structure,24-27 or plasticity in epigenetic marks28,29
imply that environmental encounters during these periods will be unusually
influential.30,31 A familiar example of a sensitive period is language
development: humans are especially responsive to language exposure during
early life.32 If there is no exposure during the sensitive age, full fluency is
rarely achieved. Immigration studies suggest that many behavioral factors are
developmentally sensitive as well.33 For example, the patterns of smoking
among immigrant children depends on the age of immigration: early
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immigrants are more likely to adopt the smoking patterns of the receiving
culture (e.g., high smoking rates among American teenagers), while those
who immigrate as adults are more likely to retain the smoking patterns of
their country of origin.34,35 There is also evidence of possible early life
critical period effects for specific adult physiological features. For example,
adult obesity is associated with intrauterine environment and rapid weight
gain in infancy.36,37
The final category of model, which we call a mobility effects model,
explicitly addresses change as an exposure in and of itself (Figure 1e).
For example, one may hypothesize that children successfully adapt to their
early life conditions but those adaptations may be harmful if they encounter
a different environment in adulthood (e.g., nutritional environment).
Research on socioeconomic status sometimes posits that social mobility –
whether up or down – is itself very stressful and results in worse health.38
CHOOSING AMONG THESE MODELS
For specific combinations of exposures and outcomes, evidence on which
of the lifecourse models is most appropriate is drawn from both theoretical
considerations and empirical analyses. The models have divergent
implications regarding the statistical associations between early and midlife
exposures and the outcome. The statistical implications of each model can
be read off the diagrams and thus used to empirically assess the plausibility
of each model.12 For example, an implication of the latency model in
Figure 1d is that midlife cognitive stimulation should have no relationship
to probability of dementia after controlling for childhood educational
exposures. In other words, in the model:
Probability(dementia) = c0 + c1 * X1 + c2 * X2
the coefficient c2 should be null, while the coefficient c1 should predict
dementia. If both exposures were measured perfectly and there were no
confounders of either the childhood or the adult risk factor, this finding
would rule out the immediate risk, social trajectory, or cumulative risk
models. Alternatively, if we found that both childhood and midlife
exposures were independently predictive of the outcome, this would be
inconsistent with the immediate risk, social trajectory, or latency models
and instead suggest that a cumulative effects model characterized the
relationship between the risk factor and the outcome.
Unfortunately, the assumptions under which this approach succeeds are
very stringent and rarely completely credible. Available measures of
childhood conditions are invariably inadequate and many studies also have
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imperfect measures of the adult risk factor.39 Further, if childhood conditions
influence adult conditions (as in the social trajectory model) then these
analyses entail all of the challenges of direct/indirect effects decomposition.38-40
Finally, testing effects of mobility versus effects of beginning or final
position is challenging because of the colinearity between any two of these,
given the third. For example, adult socioeconomic status is exactly
determined by childhood socioeconomic status plus change in socioeconomic
status from childhood to adulthood.38 Convincing solutions have not been
developed, but advances may come from substantive assumptions about
possible mediators of effects; and or about the functional relationship
between any of the three and the outcome.41-43
EXPANDING THESE FRAMEWORKS TO DISTINGUISH
DEVELOPMENT FROM DISEASE
Many important health conditions, including dementia and disability,
reflect the intersection of developmental processes, pathological or disease
processes, and recovery or resilience. These three components may have
distinct antecedents. The criteria for clinical diagnoses of Alzheimer’s
disease include a threshold component based on deficits in specific
cognitive domains.44 Although most diagnostic criteria include consideration
of whether the deficit represents a decline from prior functioning, ceiling
effects in currently used measurement scales make it difficult to identify
deficits in very high performing individuals. As a result, deficits are
intrinsically related to performance below a threshold.
Whether or not a person performs below a cognitive threshold may be
influenced by attained cognitive skills (e.g., IQ), a pathologic process (e.g.,
ischemia induced neural damage or deposition of amyloid plaques) in the
brain, or cognitive plasticity or resilience that enables maintenance of
function even after an individual incurs neurologic damage. For example,
Figure 2a contrasts two very different hypothetical lifecourse cognitive
trajectories. For both individuals, cognitive performance meets the criteria
for dementia at the same age. However, one individual experienced a longer
period of cognitive development in early life, and then a much faster rate of
decline, perhaps due to a more severe or aggressive type of dementia. The
other individual ceased enhancement of cognitive skills relatively early in
life, but then experienced a slow rate of cognitive decline during old age.
Modeling age of dementia diagnosis (or risk of dementia diagnosis) does
not fully distinguish between these two distinct pathways. Similarly, in
Figure 2b, one cognitive trajectory reflects a series of mild strokes, each
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causing modest cognitive decrements, with essentially no post-stroke
cognitive recovery. The other trajectory reflects a series of severe strokes,
each followed by substantial cognitive recovery. These two individuals
meet the threshold for dementia at roughly the same time, but the factors
that influenced the severity of stroke versus stroke recovery are probably
quite different.

Fig. 2. Alternative cognitive trajectories across the lifecourse, resulting in meeting
threshold criteria at the same age. (a) Longer period of cognitive development but
faster rate of age-related decline. (b) More severe cognitive decrements after stroke,
but greater neurologic recovery.

Conversion to a clinically recognized dementia is an important outcome
to the extent that this is the point where individuals are likely to lose
independence, require greater services, and place greater burden on
caregivers. Such considerations lead clinicians naturally to focus research
on the endpoint of dementia diagnosis. However, defining diagnosis as the
outcome of interest forces unnecessary and unrealistic assumptions about
the nature of the disease under study. Dementia is a spectrum disorder, and
the identification of cases involves applying arbitrary thresholds to a
continuous process.45 Both the major underlying pathologies that are
understood to cause dementia and cognitive decline, and the behavioral
manifestation of those pathologies, are exhibited quantitatively.46 Even
individuals with low cognitive scores within the “normal” range are at
elevated risk of mortality and institutionalization,47,48 suggesting the
underlying biological process of cognitive decline may best be characterized
as a continuous – instead of a threshold – marker of risk. Breaking a
continuous outcome into discrete categories through the application of
arbitrary thresholds, even if clinically well-informed, is often bad statistical
practice.49 Moreover, conflation of the outcome in this way is likely to
create unnecessary barriers to identifying exposures that influence either
cognitive development or the disease process that results in decline. This is
especially problematic in the case of dementia, because normal variability

Implications of Lifecourse Epidemiology

497

in cognitive test performance among adults is much larger than variability
in the rate of decline or disease development.
Longitudinal study designs combined with analyses examining changes
in indicators of disease or functional outcomes are a better option. Lifecourse
models can reflect the distinct influences of developmental processes, disease
processes, and recovery/resilience. These models explicitly represent the
hypothesized causal mechanism linking any specific risk factor to dementia.
Often, early life factors are likely to influence late life disease because of
their effects on development, and therefore vulnerability to physiologic
insults encountered later in life. Figure 3 shows one possible model, in which
early life conditions directly influence neurologic development and also the
development of certain types of neurologic disease, but do not directly affect
recovery/resilience.

Fig. 3. Lifecourse model distinguishing between developmental, pathological, and
recovery processes linking education or cognitive engagement to dementia.

In this hypothetical model, adult cognitive stimulation influences
recovery after neurologic injury, but has no direct effect on either early life
neurologic development or the risk of developing pathologies that harm
cognitive function (e.g., Alzheimer’s or cerebrovascular disease). This model
shows the co-occurrence of stimulation and pathology as a single variable on
the pathway between cognitive stimulation and cognitive recovery. This is to
represent the (testable) hypothesis that cognitive stimulation is only
important in the context of injury or disease.50 This diagram also illustrates a

498

Public Health Reviews, Vol. 32, No 2

serious potential bias in lifecourse research: early indicators of disease may
influence exposure to risk factors, for example, if small cognitive impairments
in early stages of dementia lead individuals to withdraw from cognitively
challenging activities. These expanded models can be valuable for research
on many types of complex health conditions because they express and
illustrate how to empirically test hypothesized causal mechanisms by which
lifecourse risk factors affect the outcome. We now turn to discussing how
recognition of lifecourse factors can inform research on adult risk factors
and adult disease.
POTENTIAL FOR CONFOUNDING BY EARLY LIFE CONDITIONS
Confounding bias arises when there is a common cause of the exposure and
outcome variables.51-53 For example, in Figure 1d, we would say that
childhood education confounds the association between adult cognitive
stimulation and dementia, because childhood education influences both,
but the effect of education is not mediated by adult cognitive stimulation.
Early life conditions are possible confounders in chronic disease research,
because childhood exposures are often strong predictors of adult risk
factors, such as socioeconomic position (SEP), diet and other behaviors,54-56
and cardiovascular and immune function,4,57-59 all factors believed to be
important in determining cognitive performance level in later life. In most
studies, childhood conditions are either measured poorly or not measured
at all. If one were attempting to test a social trajectory versus cumulative
effects model, for example, the adequacy of measurement of early and late
life exposures is critical. Often early life exposures are measured with
relatively more error than late life exposures. Thus, parameter estimates for
early life exposures will be biased towards the null, leading to a risk of
spuriously rejecting the cumulative effects model in favor of the social
trajectory model. The proliferation of longitudinal studies with multiple
measures of the same construct (e.g., SEP) across time may help address
the problem.35,60 However, even with operational measures of early-life
conditions, fully eliminating confounding bias depends on accurately
modeling the cascade of “upstream” lifecourse exposures that influence
adult risk factors and health outcomes.30
THE IMPORTANCE OF MODELING CHANGE INSTEAD OF LEVEL
As suggested by the discussion above and Figure 2, the findings of
lifecourse epidemiology imply that if we are interested in identifying
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determinants of the pathological process (e.g., plaque deposition), the
appropriate outcomes are markers of the pathological process. Exclusive
use of cognitive performance at any given age, or even “onset” of disease
as a surrogate outcome is a weak design because there are many influences
other than pathology that contribute to variability in performance. Rather,
to study the development of pathologies related to aging, it is important to
focus on indicators of the accumulation of pathology. This is often
impractical, and therefore studies of changes in performance across time
may be a suitable endpoint. Although disease onset may appear to
intrinsically correspond with a change in function, this is often misleading.
Many diseases have roots years, decades, or even generations prior to the
date of diagnosis or even the earliest clinical symptoms.
A leading hypothesized mechanism linking education and dementia is
that education may reduce risk of manifesting cognitive impairment in the
face of a given level of neuropathology.59,60 Education probably affects
neurologic development61,62 and cognitive skills may likewise influence
attained education. But this association tells us little about the etiology of,
for example, amyloid plaques. In research on the development of agerelated pathology, the effects of education on early life cognitive function
may simply be “noise.” However, the developmental effects of education
are likely to be huge,61,63-65 so this noise is a serious impediment to research.
In a community population of middle-aged or “young-old” individuals,
the cognitive performance differences associated with an attained year of
education are sometimes several times as large as the cognitive performance
differences associated with a chronological year of age (calculations
available from the authors). Age-related change becomes more important
among older samples, but even in quite aged populations, a great deal of the
cross-sectional variance in cognitive function is attributable to stable
personal characteristics such as education.
Focusing on cognitive decline or change may also help avoid conflation
of cohort differences with aging effects. Conceptually, a birth cohort
represents a unique social category. The life chances of individuals within
a birth cohort will be affected by intra-cohort characteristics (e.g.,
demographic composition of the cohort), inter-cohort characteristics (e.g.,
relative size compared to other generations). Longitudinal studies have
reported significant cohort differences in baseline cognitive performance,
such that successive generations appear to have better cognitive test
performance, differences which are not fully attributable to schooling.66-68
In cross-sectional designs, this pattern will tend to overstate the effect of
aging because older individuals differ from younger individuals in both age
and birth cohort. It is necessary to examine rate of change to understand the
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effects of aging per se. Although there may be differences in rate of
cognitive decline across cohorts, evidence for this is much more mixed.67,69,70
Cognitive decline may also be a better predictor of subsequent physical
outcomes than cognitive level, due to the improved capacity to capture
change over time.71,72 Given the dynamic nature of cognitive functioning,
there may be substantial measurement errors in cognitive function measured
cross-sectionally. Cognitive trajectories may be a more accurate
characterization of the ongoing process of cognitive aging. Conversely,
maintenance of cognitive function, even relatively low but stable function,
may be reflective of a successful cognitive aging trajectory. With thresholdbased outcomes such as onset of dementia, healthy individuals with low but
largely stable cognitive function may be categorized as demented with only
a small decrement in performance due to a transient factor.
Insufficient analytic distinctions between determinants of development
and determinants of disease may have contributed to the longstanding
debate regarding the effects of education on dementia and cognitive aging.
A first generation of studies found that education predicted higher baseline
cognition levels, reduced risk of cognitive impairment (performance below
a threshold), and reduced risk of dementia in the elderly.73-84 Results from a
number of early studies suggested that education slowed the rate of
cognitive decline.85 However, these results were challenged by several
subsequent reports using improved longitudinal methods, and the overall
association is now in question.8,9,86-89 Change-point models that flexibly
model rate of decline prior to the formal diagnosis of dementia indicate that
the association between education and level of function might be in the
opposite direction as the association between education and rate of change.90
Despite the above discussion, in some cases, level of functioning is more
substantively important than rate of change. For example, projections of disease
burden and assessments of individual clinical needs may need to incorporate
information on diagnoses and other criteria based on level of performance.91
LIFELONG ACCUMULATION OF RISK CONTRIBUTES
TO SELECTION AND SURVIVOR BIAS IN STUDIES OF AGING
Studies of early life determinants of adult health are potentially subject to
severe bias from selective survival: the early life adversity may influence
the chance of surviving to old age, so the only elderly who experienced
extreme childhood adversity are those with some other protective factor.39
In extreme forms this phenomena has been called “reverse epidemiology”.92
This bias can also apply to adult risk factors, and is thought to account for
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the mixed findings regarding the association between cigarette smoking
and dementia among older adults. This association generally attenuates in
older samples, presumably because the lethality of smoking results in
highly winnowed populations of very old smokers.93 In the example of
education and cognitive function, education promotes survival, and thus
low-education elderly may have other unobserved, beneficial personal
traits. If these traits influence health, they would bias any estimate of the
association between education and health among the survivors. Because of
the association between education and cognitive engagement, the same
bias may apply to estimates of the association between adult cognitive
activities and health. Such selection bias can be addressed analytically
using common missing data methods such as inverse probability weighting
to account for competing risks if the other factors are measured.94,95 In
many instances, it has been shown that although this bias is a theoretical
possibility, it is not severe unless survival is quite low (e.g., in very old
samples). Studies of individuals above age 80 or 90, however, may face
severe bias due to selective survival.
HETEROGENEOUS EXPOSURE EFFECTS FOR DETERMINANTS
OF ADULT HEALTH
The vast majority of biomedical research focuses on the effects of treatment
on the population average health (either overall average or within specified
population subgroups). However, there is no reason to assume that exposure
has the same effect on everyone in a population, or even everyone within a
pre-specified subgroup.96 There is growing recognition that focusing
exclusively on average effects may be misleading and inappropriate.97,98 We
do not expect medical interventions to affect all individuals similarly: we
take it for granted that medical treatments are targeted to those individuals
most likely to benefit (e.g., anti-hypertensive medications are given to
individuals with hypertension, not normotensive individuals). The field of
personalized genetics is premised on the hope that there are many heretofore
unmeasured genetic characteristics that determine treatment responsiveness.
Extending this idea to social conditions, we can see that unmeasured
social risk factors may also modify the effects of exposure for any type of
adult risk factor. Early life adversity may exert an influence on health and
well-being throughout life so that individuals who arrive at old age as “low
performers” may already have experienced a very distinct life history of
adverse social conditions prior to the initiation of a study. These exposures
may modify the response of the individual to new exposures or treatments.
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As a result, when considering any adult risk factor, the effects on “high
performers” may be very different than the effects on “low performers”. For
example, aging may result in faster cognitive decline among “low performers”
who are already at risk in late middle-age, and have less severe affects on
“high performers” who arrive at late middle-age with a lifelong cumulative
advantage. Modeling this heterogeneity can be challenging. For example,
our ability to detect differences in the pace of cognitive change over time
requires cognitive outcome measures with interval level scaling properties.
Brief mental status tests and single domain assessments rarely satisfy such
strict requirements. If such measures were available, we would anticipate an
increasing variability in cognitive function across age, as in Figure 4.

Fig. 4. Individuals who experience advantage across life and arrive at middle age
with high cognitive function may experience cognitive decline more slowly than
those who encounter disadvantage across life. If so, this will result in greater
increasing variability in cognitive function across age.

The standard approach to examine possible variation in exposure effects
is to include an interaction between the exposure and observed covariates
(e.g., low socioeconomic status as a child) in the regression model. At the
very least, current studies using interaction terms to assess heterogeneity in
average exposure effects should conduct and report subgroup analyses
(with appropriate account for multiple testing).99 However, treatment
responsiveness may differ across unmeasured or unknown personal traits.
There are alternative methods that can explicitly model heterogeneous
treatment effects on high and low baseline performers, without explicitly
specifying interaction models. Quantile regression models can be used to
describe the effect of the risk factor on the entire distribution of the outcome,
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rather than just the mean as in conventional ordinary least squares regression
models. One study using quantile regression found variations in the
association between early life influences and adult body mass index (BMI).
Among smaller women, birth weight was strongly associated with adult
BMI while maternal weight gain was strongly associated with adult BMI
among larger women.100 Arguably, individuals at the extreme end of the
cognitive distribution are of greater concern for population health than
individuals at the mean. Furthermore, rate of change for any given percentile
may be dependent on that percentile. To date, no studies have considered
how cognitive trajectories might differ for those at different parts of the
distribution. Since continuous measures are generally more sensitive to
group differences than categorical outcomes, quantile methods may also
better capture differences in associations between various risk factors and
continuous measure of cognition.
CONCLUSIONS AND FUTURE RESEARCH DIRECTIONS
A large body of evidence now indicates that many adult chronic diseases
are shaped by early life exposures. Although the importance of a lifecourse
approach to understanding chronic disease is increasingly recognized,
public health interventions applying these principles have been limited.
When designing interventions, it is valuable to clearly articulate the
lifecourse model assumed to link the exposure and the outcome, and
identify lifecourse periods when the exposure can be changed. If there is a
single early life sensitive period for a specific exposure-outcome
combination, it may be useless to initiate interventions later in life. If harm
accumulates slowly throughout life, interventions to change exposure in
adulthood may take years before they show benefits. Explicit recognition of
lifecourse models can help improve design and effectiveness of future
intervention programs to promote healthy aging.7 Public health interventions
informed by a lifecourse perspective have focused on time points presumed
to have special plasticity, such as early childhood. Researchers have
advocated that maternal and child health interventions using a lifecourse
approach include: 1) information strategies that use age-appropriate
messages and venues to disseminate health information across the lifespan;
2) administrative strategies that link health services across the life span;
3) organizational strategies that reconfigure programs to reflect integrated
health goals and 4) environmental strategies that address community
building and environmental exposure.101-104 Early Childhood Comprehensive
Systems enacted by several US states already incorporate a lifecourse
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perspective and use such a multi-pronged approach.105 Recent developments
in trials of pharmaceutical treatments for Alzheimer’s disease, such as
amyloid immunotherapy, suggest that intervening early may be essential.
Treatments may be most effective at interrupting the neuropathological
process long before conventional diagnostic criteria are met, although the
optimal timing is unknown.106 The public health challenge is to improve our
understanding of the lifecourse processes linking modifiable exposures and
major diseases and use this information to inform effective interventions
across the lifespan. Although preventive interventions early in life may
have larger benefits than comparable interventions later in the lifecourse for
some outcomes, most adult health outcomes presumably reflect an ongoing
interplay between biological, environmental and social factors. Emerging
evidence suggests physiologic and functional plasticity in many domains
persists throughout life.107-109 Interventions targeting time points in mid or
late adulthood may clearly have substantial benefits.
Articulating and applying theoretical models of lifecourse processes
(e.g., immediate risk, social trajectory, cumulative effects, latency, or
mobility) to longitudinal data can help clarify interpretation and comparison
of regression results. Even when the focus of research is late life risk
factors, it is important to consider the role of lifecourse processes in
generating the observed associations between the risk factor and the
outcome; creating barriers to intervention efforts to remediate the risk
factor; or modifying the responsiveness of individuals to the risk factor.
Explicit theorizing about lifecourse processes will help inform better
intervention design, even when the intervention is for older adults.7 Finally,
lifecourse models are important as we project into the future the health of
an aging population and consider priorities for current health investments.
In coming years, we may experience either substantial health benefits or
health costs due to investments made during the early lives of aging cohorts.
Likewise, investments made now in generations of children or younger
adults may have health consequences for decades into the future.
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